Further evidence that luteinizing hormone-releasing hormone also is follicle-stimulating hormone-releasing hormone

Phyllis M. Wise, Naomi Rance, George D. Barr, Charles A. Barraclough

    Research output: Contribution to journalArticle

    Abstract

    While LHRH evokes the release of both LH and FSH under a wide spectrum of experimental conditions, this hormone has not been shown to induce the discharge of FSH unaccompanied by LH release. As a consequence, the possibility that a separate FSHRH exists has not been discounted. These experiments were designed to demonstrate that LHRH is capable of promoting marked increases in plasma FSH concomitant with physiologically insignificant changes in plasma LH and, thus, that LHRH is also FSHRH. Seven groups of cyclic female rats received phenobarbital at 1200 h proestrus to block spontaneous preovulatory LH and FSH surges. These various groups then were subdivided according to whether phosphate-buffered saline (PBS), LHRH, or both was infused (iv). The experimental protocol consisted of infusing material for an initial 30 min (priming period), stopping the infusion for 30 min (rest interval), and again infusing material for an additional 210 min (maintenance period). When PBS was infused during the priming and maintenance periods, plasma LH and FSH remained basal. In contrast, when a total of 25 ng LHRH was infused during the first 30 min, followed by the infusion of a total of 17.5 ng LHRH during the 210-min maintenance period, plasma FSH concentrations increased to levels comparable to those observed during the proestrous preovulatory FSH surge. In these animals, plasma LH increased to only 8% of proestrous values, which was insufficient to alter plasma estradiol and progesterone concentrations 60 min after the beginning of the initial LHRH infusion period. When the priming dose of LHRH was decreased by 50% (12.5 ng), the peak plasma FSH concentrations, which were induced by infusing 17.5 ng LHRH during the maintenance period, also were halved. Infusion of LHRH only during the priming or maintenance period did not appreciably affect basal plasma FSH concentrations. In Nembutal-blocked proestrous rats, low intensity electrical stimulation of the preoptic area was performed in an attempt to induce the endogenous reease of LHRH in patterns and concentrations similar to those produced by our infusion protocol. Such stimuli induced the selective increase in plasma FSH. To our knowledge, these studies are the first to demonstrate that synthetic LHRH or medial preoptic area electrical stimulation can induce marked increase in plasma FSH without prior or simultaneous large increments in plasma LH; thus, they provide additional evidence that LHRH also is FSHRH.

    Original languageEnglish (US)
    Pages (from-to)940-947
    Number of pages8
    JournalEndocrinology
    Volume104
    Issue number4
    DOIs
    StatePublished - 1979

    Fingerprint

    Follicle Stimulating Hormone
    Gonadotropin-Releasing Hormone
    Hormones
    Maintenance
    Preoptic Area
    Electric Stimulation
    Phosphates
    Proestrus
    Pentobarbital
    Phenobarbital
    Progesterone
    Estradiol

    ASJC Scopus subject areas

    • Endocrinology

    Cite this

    Further evidence that luteinizing hormone-releasing hormone also is follicle-stimulating hormone-releasing hormone. / Wise, Phyllis M.; Rance, Naomi; Barr, George D.; Barraclough, Charles A.

    In: Endocrinology, Vol. 104, No. 4, 1979, p. 940-947.

    Research output: Contribution to journalArticle

    Wise, Phyllis M. ; Rance, Naomi ; Barr, George D. ; Barraclough, Charles A. / Further evidence that luteinizing hormone-releasing hormone also is follicle-stimulating hormone-releasing hormone. In: Endocrinology. 1979 ; Vol. 104, No. 4. pp. 940-947.
    @article{1892e8beaca34267824c5ec3f1049333,
    title = "Further evidence that luteinizing hormone-releasing hormone also is follicle-stimulating hormone-releasing hormone",
    abstract = "While LHRH evokes the release of both LH and FSH under a wide spectrum of experimental conditions, this hormone has not been shown to induce the discharge of FSH unaccompanied by LH release. As a consequence, the possibility that a separate FSHRH exists has not been discounted. These experiments were designed to demonstrate that LHRH is capable of promoting marked increases in plasma FSH concomitant with physiologically insignificant changes in plasma LH and, thus, that LHRH is also FSHRH. Seven groups of cyclic female rats received phenobarbital at 1200 h proestrus to block spontaneous preovulatory LH and FSH surges. These various groups then were subdivided according to whether phosphate-buffered saline (PBS), LHRH, or both was infused (iv). The experimental protocol consisted of infusing material for an initial 30 min (priming period), stopping the infusion for 30 min (rest interval), and again infusing material for an additional 210 min (maintenance period). When PBS was infused during the priming and maintenance periods, plasma LH and FSH remained basal. In contrast, when a total of 25 ng LHRH was infused during the first 30 min, followed by the infusion of a total of 17.5 ng LHRH during the 210-min maintenance period, plasma FSH concentrations increased to levels comparable to those observed during the proestrous preovulatory FSH surge. In these animals, plasma LH increased to only 8{\%} of proestrous values, which was insufficient to alter plasma estradiol and progesterone concentrations 60 min after the beginning of the initial LHRH infusion period. When the priming dose of LHRH was decreased by 50{\%} (12.5 ng), the peak plasma FSH concentrations, which were induced by infusing 17.5 ng LHRH during the maintenance period, also were halved. Infusion of LHRH only during the priming or maintenance period did not appreciably affect basal plasma FSH concentrations. In Nembutal-blocked proestrous rats, low intensity electrical stimulation of the preoptic area was performed in an attempt to induce the endogenous reease of LHRH in patterns and concentrations similar to those produced by our infusion protocol. Such stimuli induced the selective increase in plasma FSH. To our knowledge, these studies are the first to demonstrate that synthetic LHRH or medial preoptic area electrical stimulation can induce marked increase in plasma FSH without prior or simultaneous large increments in plasma LH; thus, they provide additional evidence that LHRH also is FSHRH.",
    author = "Wise, {Phyllis M.} and Naomi Rance and Barr, {George D.} and Barraclough, {Charles A.}",
    year = "1979",
    doi = "10.1210/endo-104-4-940",
    language = "English (US)",
    volume = "104",
    pages = "940--947",
    journal = "Endocrinology",
    issn = "0013-7227",
    publisher = "The Endocrine Society",
    number = "4",

    }

    TY - JOUR

    T1 - Further evidence that luteinizing hormone-releasing hormone also is follicle-stimulating hormone-releasing hormone

    AU - Wise, Phyllis M.

    AU - Rance, Naomi

    AU - Barr, George D.

    AU - Barraclough, Charles A.

    PY - 1979

    Y1 - 1979

    N2 - While LHRH evokes the release of both LH and FSH under a wide spectrum of experimental conditions, this hormone has not been shown to induce the discharge of FSH unaccompanied by LH release. As a consequence, the possibility that a separate FSHRH exists has not been discounted. These experiments were designed to demonstrate that LHRH is capable of promoting marked increases in plasma FSH concomitant with physiologically insignificant changes in plasma LH and, thus, that LHRH is also FSHRH. Seven groups of cyclic female rats received phenobarbital at 1200 h proestrus to block spontaneous preovulatory LH and FSH surges. These various groups then were subdivided according to whether phosphate-buffered saline (PBS), LHRH, or both was infused (iv). The experimental protocol consisted of infusing material for an initial 30 min (priming period), stopping the infusion for 30 min (rest interval), and again infusing material for an additional 210 min (maintenance period). When PBS was infused during the priming and maintenance periods, plasma LH and FSH remained basal. In contrast, when a total of 25 ng LHRH was infused during the first 30 min, followed by the infusion of a total of 17.5 ng LHRH during the 210-min maintenance period, plasma FSH concentrations increased to levels comparable to those observed during the proestrous preovulatory FSH surge. In these animals, plasma LH increased to only 8% of proestrous values, which was insufficient to alter plasma estradiol and progesterone concentrations 60 min after the beginning of the initial LHRH infusion period. When the priming dose of LHRH was decreased by 50% (12.5 ng), the peak plasma FSH concentrations, which were induced by infusing 17.5 ng LHRH during the maintenance period, also were halved. Infusion of LHRH only during the priming or maintenance period did not appreciably affect basal plasma FSH concentrations. In Nembutal-blocked proestrous rats, low intensity electrical stimulation of the preoptic area was performed in an attempt to induce the endogenous reease of LHRH in patterns and concentrations similar to those produced by our infusion protocol. Such stimuli induced the selective increase in plasma FSH. To our knowledge, these studies are the first to demonstrate that synthetic LHRH or medial preoptic area electrical stimulation can induce marked increase in plasma FSH without prior or simultaneous large increments in plasma LH; thus, they provide additional evidence that LHRH also is FSHRH.

    AB - While LHRH evokes the release of both LH and FSH under a wide spectrum of experimental conditions, this hormone has not been shown to induce the discharge of FSH unaccompanied by LH release. As a consequence, the possibility that a separate FSHRH exists has not been discounted. These experiments were designed to demonstrate that LHRH is capable of promoting marked increases in plasma FSH concomitant with physiologically insignificant changes in plasma LH and, thus, that LHRH is also FSHRH. Seven groups of cyclic female rats received phenobarbital at 1200 h proestrus to block spontaneous preovulatory LH and FSH surges. These various groups then were subdivided according to whether phosphate-buffered saline (PBS), LHRH, or both was infused (iv). The experimental protocol consisted of infusing material for an initial 30 min (priming period), stopping the infusion for 30 min (rest interval), and again infusing material for an additional 210 min (maintenance period). When PBS was infused during the priming and maintenance periods, plasma LH and FSH remained basal. In contrast, when a total of 25 ng LHRH was infused during the first 30 min, followed by the infusion of a total of 17.5 ng LHRH during the 210-min maintenance period, plasma FSH concentrations increased to levels comparable to those observed during the proestrous preovulatory FSH surge. In these animals, plasma LH increased to only 8% of proestrous values, which was insufficient to alter plasma estradiol and progesterone concentrations 60 min after the beginning of the initial LHRH infusion period. When the priming dose of LHRH was decreased by 50% (12.5 ng), the peak plasma FSH concentrations, which were induced by infusing 17.5 ng LHRH during the maintenance period, also were halved. Infusion of LHRH only during the priming or maintenance period did not appreciably affect basal plasma FSH concentrations. In Nembutal-blocked proestrous rats, low intensity electrical stimulation of the preoptic area was performed in an attempt to induce the endogenous reease of LHRH in patterns and concentrations similar to those produced by our infusion protocol. Such stimuli induced the selective increase in plasma FSH. To our knowledge, these studies are the first to demonstrate that synthetic LHRH or medial preoptic area electrical stimulation can induce marked increase in plasma FSH without prior or simultaneous large increments in plasma LH; thus, they provide additional evidence that LHRH also is FSHRH.

    UR - http://www.scopus.com/inward/record.url?scp=0018741786&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0018741786&partnerID=8YFLogxK

    U2 - 10.1210/endo-104-4-940

    DO - 10.1210/endo-104-4-940

    M3 - Article

    VL - 104

    SP - 940

    EP - 947

    JO - Endocrinology

    JF - Endocrinology

    SN - 0013-7227

    IS - 4

    ER -